KIWA BIO-TECH PRODUCTS GROUP CORP (KWBT) Financial Statements
KIWA BIO-TECH PRODUCTS GROUP CORP (KWBT) files with the U.S. Securities and Exchange Commission under CIK 0001159275. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2019
- Revenue
- $40.09 million
- Net Income
- -$6.64 million
- Total Assets
- $24.07 million
- Net Cash from Operations
- $183.07 thousand
Fiscal year ended Dec 31, 2019. Latest periodic SEC filing: May 29, 2020. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for KWBT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History